Skip to content

A clinical study of fire-needle therapy combined with HXJD formula in the treatment of plaque psoriasis

A clinical study of fire-needle therapy combined with HXJD formula in the treatment of plaque psoriasis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009206
Enrollment
Unknown
Registered
2016-08-31
Start date
2013-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

the treatment group:fire-needle therapy + orally use HXJD formula + externally use Vaseline cream
Control group:orally use HXJD formula + externally use Vaseline cream

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Outpatients or resident patients between 18-65 years old, meeting the diagnosis of psoriasis vulgaris; 2. Skin lesions last 1 year, in line with blood stasis psoriasis of TCM diagnostic criteria; 3. Discontinued treatment for more than a week; 4. Signed the informed consent; 5. The skin lesion of psoriasis is less than 30%.

Exclusion criteria

Exclusion criteria: 1. Infection, pregnancy, childbirth, trauma or other stress state; 2. Serious heart, liver and kidney disease, diabetes, and mental illness; 3. Allergic to study medicine or some ingredients; 4. Refused to fire needle treatment; 5. Scar constitution; 6. Joints, pustules, erythrodermic psoriasis; 7. Taking part in clinical trials of patients with other drugs.

Design outcomes

Primary

MeasureTime frame
PASI score;

Secondary

MeasureTime frame
skin lesion individual symptom scores;itching index;The quality of life score;TCM syndrome score;HAMA score;

Countries

China

Contacts

Public ContactYan-ping Bai

China-Japan Friendship Hospital

zhi@tsinghua.edu.cn+86 13910758509

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026